Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart failure care under the microscope: do german hospitals follow the rules?

NCT ID NCT06004453

Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checked how well German hospitals and heart failure clinics follow recommended treatments for people with a certain type of heart failure (HFrEF) after a serious episode. Researchers looked at the care of 899 patients to see if guidelines were being used. The goal was to understand where care is good and where it can be improved.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

899 people

The number who actually took part.

Started

Apr 2023

Finished

Jan 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Heart failure with reduced ejection fraction patients with a recent decompensation event

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients who provide written informed consent to participate in the study 2. Male or female patients ≥ 18 years of age 3. Patients with diagnosis of heart failure with reduced ejection fraction (HFrEF) and HF treatment according to the summaries of product characteristics (SmPCs) 4. Decompensation event up to three months prior to inclusion Exclusion Criteria: 1. Simultaneous or planned participation in an interventional research study 2. Participation in this study at another site e.g. in a HFU network 3. Patients incapable of understanding and signing the informed consent form

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

Contacts and locations

Locations

  • Novartis Investigative Site

    Heidelberg, Baden-Wurttemberg, 69115, Germany

  • Novartis Investigative Site

    Ludwigsburg, Baden-Wurttemberg, 71640, Germany

  • Novartis Investigative Site

    Muellheim Im Markgraeflerland, Baden-Wurttemberg, 79379, Germany

  • Novartis Investigative Site

    Frankfurt am Main, Hesse, 60590, Germany

  • Novartis Investigative Site

    Kassel, Hesse, 34121, Germany

  • Novartis Investigative Site

    Braunschweig, Lower Saxony, 38126, Germany

  • Novartis Investigative Site

    Winsen, Lower Saxony, 21423, Germany

  • Novartis Investigative Site

    Löhne, North Rhine-Westphalia, 32584, Germany

  • Novartis Investigative Site

    Frankenthal, Rhineland-Palatinate, 67227, Germany

  • Novartis Investigative Site

    Ingelheim, Rhineland-Palatinate, 55218, Germany

  • Novartis Investigative Site

    Kaiserslautern, Rhineland-Palatinate, 67655, Germany

  • Novartis Investigative Site

    Kaiserslautern, Rhineland-Palatinate, 67657, Germany

  • Novartis Investigative Site

    Kleinblittersdorf, Saarland, 66271, Germany

  • Novartis Investigative Site

    Chemnitz, Saxony, 09113, Germany

  • Novartis Investigative Site

    Leipzig, Saxony, 04209, Germany

  • Novartis Investigative Site

    Limbach-Oberfrohna, Saxony, 09212, Germany

  • Novartis Investigative Site

    Pirna, Saxony, 01796, Germany

  • Novartis Investigative Site

    Halle, Saxony-Anhalt, 06120, Germany

  • Novartis Investigative Site

    Jerichow, Saxony-Anhalt, 39319, Germany

  • Novartis Investigative Site

    Berlin, State of Berlin, 10365, Germany

  • Novartis Investigative Site

    Gera, Thuringia, 07551, Germany

  • Novartis Investigative Site

    Aichach, 86551, Germany

  • Novartis Investigative Site

    Amberg, 92224, Germany

  • Novartis Investigative Site

    Bad Homburg, 61348, Germany

  • Novartis Investigative Site

    Bad Neustadt an der Saale, 97616, Germany

  • Novartis Investigative Site

    Bad Vilbel, 61118, Germany

  • Novartis Investigative Site

    Bechhofen, 66894, Germany

  • Novartis Investigative Site

    Berlin, 10559, Germany

  • Novartis Investigative Site

    Berlin, 13053, Germany

  • Novartis Investigative Site

    Bexbach, 66450, Germany

  • Novartis Investigative Site

    Biedenkopf, 35216, Germany

  • Novartis Investigative Site

    Bitterfeld-Wolfen, 06749, Germany

  • Novartis Investigative Site

    Breuberg, 64747, Germany

  • Novartis Investigative Site

    Brilon, 59929, Germany

  • Novartis Investigative Site

    Bruchsal, 76646, Germany

  • Novartis Investigative Site

    Brüel, 19412, Germany

  • Novartis Investigative Site

    Coburg, 96450, Germany

  • Novartis Investigative Site

    Coswig, 06869, Germany

  • Novartis Investigative Site

    Dessau, 06847, Germany

  • Novartis Investigative Site

    Dinkelsbühl, 91550, Germany

  • Novartis Investigative Site

    Dresden, 01277, Germany

  • Novartis Investigative Site

    Dresden, 01397, Germany

  • Novartis Investigative Site

    Düsseldorf, 40217, Germany

  • Novartis Investigative Site

    Düsseldorf, 40225, Germany

  • Novartis Investigative Site

    Ehingen, 89584, Germany

  • Novartis Investigative Site

    Erfurt, 99097, Germany

  • Novartis Investigative Site

    Farchant, 82490, Germany

  • Novartis Investigative Site

    Freiberg, 09559, Germany

  • Novartis Investigative Site

    Fulda, 36037, Germany

  • Novartis Investigative Site

    Giengen an der Brenz, 89537, Germany

  • Novartis Investigative Site

    Göppingen, 73033, Germany

  • Novartis Investigative Site

    Hagen, 58135, Germany

  • Novartis Investigative Site

    Hamburg, 20095, Germany

  • Novartis Investigative Site

    Hamburg, 22087, Germany

  • Novartis Investigative Site

    Heidelberg, 69120, Germany

  • Novartis Investigative Site

    Homburg, 66421, Germany

  • Novartis Investigative Site

    Hoppegarten, 15366, Germany

  • Novartis Investigative Site

    Kiel, 24105, Germany

  • Novartis Investigative Site

    Kiel, 24106, Germany

  • Novartis Investigative Site

    Kitzingen, 97318, Germany

  • Novartis Investigative Site

    Kleve, 47533, Germany

  • Novartis Investigative Site

    Leipzig, 04129, Germany

  • Novartis Investigative Site

    Ludwigshafen, 67067, Germany

  • Novartis Investigative Site

    Lübeck, 23569, Germany

  • Novartis Investigative Site

    Magdeburg, 39120, Germany

  • Novartis Investigative Site

    Markkleeberg, 04416, Germany

  • Novartis Investigative Site

    Moers, 47441, Germany

  • Novartis Investigative Site

    Münster, 48149, Germany

  • Novartis Investigative Site

    Osnabrück, 49074, Germany

  • Novartis Investigative Site

    Papenburg, 26871, Germany

  • Novartis Investigative Site

    Potsdam, 14471, Germany

  • Novartis Investigative Site

    Radebeul, 01445, Germany

  • Novartis Investigative Site

    Rastatt, 76437, Germany

  • Novartis Investigative Site

    Remscheid, 42859, Germany

  • Novartis Investigative Site

    Rostock, 18107, Germany

  • Novartis Investigative Site

    Rotenburg an der Fulda, 36199, Germany

  • Novartis Investigative Site

    Rudersberg, 73635, Germany

  • Novartis Investigative Site

    Schönebeck, 39218, Germany

  • Novartis Investigative Site

    Schwandorf in Bayern, 92421, Germany

  • Novartis Investigative Site

    Siegen, 57072, Germany

  • Novartis Investigative Site

    Speyer, 67346, Germany

  • Novartis Investigative Site

    Stadtlohn, 48703, Germany

  • Novartis Investigative Site

    Stahnsdorf, 14532, Germany

  • Novartis Investigative Site

    Stuttgart, 70376, Germany

  • Novartis Investigative Site

    Ulm, 89077, Germany

  • Novartis Investigative Site

    Urbach, 99765, Germany

  • Novartis Investigative Site

    Wedemark, 30900, Germany

  • Novartis Investigative Site

    Wermsdorf, 04779, Germany

  • Novartis Investigative Site

    Wiesbaden, D-65199, Germany

  • Novartis Investigative Site

    Winsen, 21423, Germany

  • Novartis Investigative Site

    Wismar, 23966, Germany

  • Novartis Investigative Site

    Wittenberg, 06886, Germany

  • Novartis Investigative Site

    Wolfsburg, 38440, Germany

  • Novartis Investigative Site

    Würzburg, 97080, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.